Clinical Trial Update: Photodynamic Therapy (PDT) for Lower Urinary Tract Symptoms (PLUS) [Phase 2]

View source ↗

Summary

A Phase 2 trial of photodynamic therapy for benign prostatic hyperplasia sponsored by QLT Inc. was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• Photodynamic therapy (PDT) for lower urinary tract symptoms

Snippet

Sponsor: QLT Inc. | Conditions: Prostatic Hyperplasia | Phase 2 | Status: TERMINATED